litlas
Log inCreate account

David J. Grignon

Active 1988–2022

126
Papers
23,889
Citations
90
h-index
126
i10-index

Citations

Citations per year for David J. Grignon1931: 1 citations1953: 1 citations1978: 1 citations1989: 2 citations1990: 1 citations1991: 6 citations1992: 7 citations1993: 10 citations1994: 13 citations1995: 33 citations1996: 33 citations1997: 53 citations1998: 70 citations1999: 64 citations2000: 91 citations2001: 113 citations2002: 102 citations2003: 110 citations2004: 151 citations2005: 164 citations2006: 155 citations2007: 160 citations2008: 154 citations2009: 125 citations2010: 159 citations2011: 133 citations2012: 132 citations2013: 110 citations2014: 145 citations2015: 107 citations2016: 113 citations2017: 116 citations2018: 93 citations2019: 422 citations2020: 487 citations2021: 454 citations2022: 377 citations2023: 246 citations2024: 363 citations2025: 172 citations2026: 6 citations1932–1952: no citations, so these years are not shown1954–1977: no citations, so these years are not shown1979–1988: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,203 citing papers, 29.8% of this breakdownCanada: 458 citing papers, 6.2% of this breakdownUnited Kingdom: 434 citing papers, 5.9% of this breakdownItaly: 414 citing papers, 5.6% of this breakdownChina: 408 citing papers, 5.5% of this breakdownGermany: 366 citing papers, 4.9% of this breakdownFrance: 260 citing papers, 3.5% of this breakdownSpain: 235 citing papers, 3.2% of this breakdownNetherlands: 234 citing papers, 3.2% of this breakdownJapan: 223 citing papers, 3% of this breakdownAustralia: 218 citing papers, 2.9% of this breakdownSweden: 188 citing papers, 2.5% of this breakdown
0%29.8%Other 23.8%

Institutions

Fields

  • Medicine77%
  • Biochemistry, Genetics and Molecular Biology13.1%
  • Computer Science6.4%
  • Immunology and Microbiology0.7%
  • Engineering0.5%
  • Nursing0.3%
  • Other2%

Topics

  • Prostate Cancer Diagnosis and Treatment11.5%
  • Prostate Cancer Treatment and Research11.1%
  • Renal cell carcinoma treatment5.6%
  • Bladder and Urothelial Cancer Treatments3.9%
  • Renal and related cancers3.3%
  • AI in cancer detection3.2%
  • Other61.4%

Coauthors

All papers

Open in search
  1. The 2019 International Society of Urological Pathology (ISUP) Consensus Conference on Grading of Prostatic Carcinoma

    Authors: Geert J.L.H. van Leenders, Theodorus van der Kwast, David J. Grignon, Andrew Evans, Glen Kristiansen, Charlotte F. Kweldam, Geert Litjens, Jesse K. McKenney, Jonathan Melamed, N. Mottet, Gladell P. Paner, Hemamali Samaratunga, Ivo G. Schoots, Jeffry Simko, Toyonori Tsuzuki, Murali Varma, Anne Y. Warren, Thomas M. Wheeler, Sean R. Williamson, Kenneth A. Iczkowski - The American Journal of Surgical Pathology 2020 cited by 685

  2. Artificial intelligence for diagnosis and grading of prostate cancer in biopsies: a population-based, diagnostic study

    Authors: Peter Ström, Kimmo Kartasalo, Henrik Olsson, Leslie Solorzano, Brett Delahunt, Daniel M. Berney, David G. Bostwick, Andrew Evans, David J. Grignon, Peter A. Humphrey, Kenneth A. Iczkowski, James G. Kench, Glen Kristiansen, Theodorus van der Kwast, Kátia Ramos Moreira Leite, Jesse K. McKenney, Jon Oxley, Chin-Chen Pan, Hemamali Samaratunga, John R. Srigley, Hiroyuki Takahashi, Toyonori Tsuzuki, Murali Varma, Ming Zhou, Johan Lindberg, Cecilia Lindskog, Pekka Ruusuvuori, Carolina Wählby, Henrik Grönberg, Mattias Rantalainen, Lars Egevad, Martin Eklund - The Lancet Oncology 2020 cited by 615

  3. The International Society of Urological Pathology (ISUP) Grading System for Renal Cell Carcinoma and Other Prognostic Parameters

    Authors: Brett Delahunt, John C. Cheville, Guido Martignoni, Peter A. Humphrey, Cristina Magi‐Galluzzi, Jesse K. McKenney, Lars Egevad, Ferrán Algaba, Holger Moch, David J. Grignon, Rodolfo Montironi, John R. Srigley - The American Journal of Surgical Pathology 2013 cited by 856

  4. Artificial intelligence assistance significantly improves Gleason grading of prostate biopsies by pathologists

    Authors: Wouter Bulten, Maschenka Balkenhol, Jean-Joël Awoumou Belinga, Américo Brilhante, Aslı Çakır, Lars Egevad, Martin Eklund, Xavier Farré, Katerina Geronatsiou, Vincent Molinié, Guilherme Pereira, Paromita Roy, Günter Saile, Paulo Salles, Ewout Schaafsma, Joëlle Tschui, Anne-Marie Vos, ISUP Pathology Imagebase Expert Panel, Hester van Boven, Robert Vink, Jeroen van der Laak, Christina Hulsbergen-van der Kaa, Geert Litjens, Brett Delahunt, Hemamali Samaratunga, David J. Grignon, Andrew J. Evans, Daniel M.Berney, Chin-Chen Pan, Glen Kristiansen, James G. Kench, Jon Oxley, Katia R.M. Leite, Jesse K. McKenney, Peter A. Humphrey, Samson W. Fine, Toyonori Tsuzuki, Murali Varma, Ming Zhou, Eva Comperat, David G. Bostwick, Kenneth A. Iczkowski, Cristina Magi-Galluzzi, John R. Srigley, Hiroyuki Takahashi, Theo van der Kwast - Modern Pathology 2020 cited by 159

  5. Radiation with or without Antiandrogen Therapy in Recurrent Prostate Cancer

    Authors: William U. Shipley, Wendy Seiferheld, Himanshu Lukka, Pierre Major, Niall M. Heney, David J. Grignon, Oliver Sartor, Maltibehn P. Patel, Jean-Paul Bahary, Anthony L. Zietman, Thomas M. Pisansky, Kenneth L. Zeitzer, C.A. Lawton, Felix Y. Feng, R.D. Lovett, Alexander G. Balogh, Luís Souhami, Seth A. Rosenthal, K. Kerlin, James J. Dignam, Stephanie L. Pugh, Howard M. Sandler - New England Journal of Medicine 2017 cited by 662

  6. Molecular Biomarkers in Localized Prostate Cancer: ASCO Guideline

    Authors: Scott E. Eggener, R. Bryan Rumble, Andrew J. Armstrong, Todd M. Morgan, Tony Crispino, Philip Cornford, Theodorus van der Kwast, David J. Grignon, Alex J. Rai, Neeraj Agarwal, Eric A. Klein, Robert B. Den, Himisha Beltran - Journal of Clinical Oncology 2019 cited by 221

  7. Papillary Renal Neoplasm With Reverse Polarity

    Authors: Khaleel I. Al‐Obaidy, John N. Eble, Liang Cheng, Sean R. Williamson, Wael Sakr, Nilesh Gupta, Muhammad T. Idrees, David J. Grignon - The American Journal of Surgical Pathology 2019 cited by 122

  8. Best Practices Recommendations in the Application of Immunohistochemistry in Urologic Pathology

    Authors: Mahul B. Amin, Jonathan I. Epstein, Thomas M. Ulbright, Peter A. Humphrey, Lars Egevad, Rodolfo Montironi, David J. Grignon, Kiril Trpkov, Antonio López-Beltrán, Ming Zhou, Pedram Argani, Brett Delahunt, Daniel M. Berney, John R. Srigley, Satish K. Tickoo, Victor E. Reuter - The American Journal of Surgical Pathology 2014 cited by 315

  9. Recurrent KRAS mutations in papillary renal neoplasm with reverse polarity

    Authors: Khaleel I. Al‐Obaidy, John N. Eble, Mehdi Nassiri, Liang Cheng, Mohammad K. Eldomery, Sean R. Williamson, Wael Sakr, Nilesh Gupta, Oudai Hassan, Muhammad T. Idrees, David J. Grignon - Modern Pathology 2019 cited by 76

  10. Recurrent KRAS mutations are early events in the development of papillary renal neoplasm with reverse polarity

    Authors: Khaleel I. Al‐Obaidy, Rola Saleeb, Kiril Trpkov, Sean R. Williamson, Ankur R. Sangoi, Mehdi Nassiri, Ondřej Hes, Rodolfo Montironi, Alessia Cimadamore, Andrés Acosta, Zainab I. Alruwaii, Ahmad Alkashash, Oudai Hassan, Nilesh Gupta, Adeboye O. Osunkoya, Joyashree D. Sen, Lee Ann Baldrige, Wael Sakr, Muhammad T. Idrees, John N. Eble, David J. Grignon, Liang Cheng - Modern Pathology 2022 cited by 38

  11. The International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia

    Authors: John R. Srigley, Brett Delahunt, John N. Eble, Lars Egevad, Jonathan I. Epstein, David J. Grignon, Ondřej Hes, Holger Moch, Rodolfo Montironi, Satish K. Tickoo, Ming Zhou, Pedram Argani - The American Journal of Surgical Pathology 2013 cited by 1,052

  12. Correcting the Shrinkage Effects of Formalin Fixation and Tissue Processing for Renal Tumors: toward Standardization of Pathological Reporting of Tumor Size

    Authors: Thu Tran, Chandru P. Sundaram, Clinton D. Bahler, John N. Eble, David J. Grignon, M. Francesca Monn, Novae B. Simper, Liang Cheng - Journal of Cancer 2015 cited by 144

  13. Duration of Androgen Deprivation in Locally Advanced Prostate Cancer: Long-Term Update of NRG Oncology RTOG 9202

    Authors: C.A. Lawton, Xiaolei Lin, Gerald E. Hanks, Herbert Lepor, David J. Grignon, Harmar D. Brereton, Meena Bedi, Seth A. Rosenthal, Kenneth L. Zeitzer, Varagur Venkatesan, Eric M. Horwitz, Thomas M. Pisansky, Harold Kim, Matthew Parliament, Rachel Rabinovitch, Mack Roach, Young Kwok, James J. Dignam, Howard M. Sandler - International Journal of Radiation Oncology*Biology*Physics 2017 cited by 138

  14. Report From the International Society of Urological Pathology (ISUP) Consultation Conference on Molecular Pathology of Urogenital Cancers

    Authors: Sean R. Williamson, Anthony J. Gill, Pedram Argani, Ying‐Bei Chen, Lars Egevad, Glen Kristiansen, David J. Grignon, Ondřej Hes - The American Journal of Surgical Pathology 2020 cited by 112

  15. EWSR1-PATZ1 fusion renal cell carcinoma: a recurrent gene fusion characterizing thyroid-like follicular renal cell carcinoma

    Authors: Khaleel I. Al‐Obaidy, Julia A. Bridge, Liang Cheng, János Sümegi, Victor E. Reuter, Ryma Benayed, Meera Hameed, Sean R. Williamson, Ondřej Hes, Fatimah Alruwaii, Jeremy P. Segal, Pankhuri Wanjari, Muhammad T. Idrees, Mehdi Nassiri, John N. Eble, David J. Grignon - Modern Pathology 2021 cited by 47

  16. Her-2/neu overexpression in muscle-invasive urothelial carcinoma of the bladder: prognostic significance and comparative analysis in primary and metastatic tumors.

    Authors: Rafael E. Jiménez, Maha Hussain, Fernando J. Bianco, Ulka N. Vaishampayan, P Tabazcka, Wael Sakr, J. Edson Pontes, David P. Wood, David J. Grignon - 2001 cited by 236

  17. TFE3 Break-apart FISH Has a Higher Sensitivity for Xp11.2 Translocation–associated Renal Cell Carcinoma Compared With TFE3 or Cathepsin K Immunohistochemical Staining Alone

    Authors: Qiu Rao, Sean R. Williamson, Shaobo Zhang, John N. Eble, David J. Grignon, Ming‐Sheng Wang, Xiao-jun Zhou, Wenbin Huang, Puay‐Hoon Tan, Gregory T. MacLennan, Liang Cheng - The American Journal of Surgical Pathology 2013 cited by 174

  18. Phase II randomized clinical trial of lycopene supplementation before radical prostatectomy.

    Authors: O Kucuk, Fazlul H. Sarkar, Wael Sakr, Zora Djurić, Michaël Pollak, Fred Khachik, Yi Wei Li, Mousumi Banerjee, David J. Grignon, John S. Bertram, John D. Crissman, Edson J. Pontes, David P. Wood - 2001 cited by 419

  19. Renal Tumors

    Authors: Puay Hoon Tan, Liang Cheng, Nathalie Rioux‐Leclercq, Maria J. Merino, George J. Netto, Victor E. Reuter, Steven S. Shen, David J. Grignon, Rodolfo Montironi, Lars Egevad, John R. Srigley, Brett Delahunt, Holger Moch - The American Journal of Surgical Pathology 2013 cited by 177

  20. Handling and Staging of Renal Cell Carcinoma

    Authors: Kiril Trpkov, David J. Grignon, Stephen M. Bonsib, Mahul B. Amin, Athanase Billis, Antonio López-Beltrán, Hemamali Samaratunga, Pheroze Tamboli, Brett Delahunt, Lars Egevad, Rodolfo Montironi, John R. Srigley - The American Journal of Surgical Pathology 2013 cited by 132

  21. Molecular Genetic Evidence Supporting the Origin of Somatic-type Malignancy and Teratoma From the Same Progenitor Cell

    Authors: Jennifer B. Kum, Thomas M. Ulbright, Sean R. Williamson, Ming‐Sheng Wang, Shaobo Zhang, Richard S. Foster, David J. Grignon, John N. Eble, Stephen D.W. Beck, Liang Cheng - The American Journal of Surgical Pathology 2012 cited by 80

  22. Renal Cell Carcinoma With Chromosome 6p Amplification Including the TFEB Gene

    Authors: Sean R. Williamson, David J. Grignon, Liang Cheng, Laura Favazza, Dibson Gondim, Shannon Carskadon, Nilesh Gupta, Dhananjay Chitale, Shanker Kalyana‐Sundaram, Nallasivam Palanisamy - The American Journal of Surgical Pathology 2016 cited by 76

  23. Report From the International Society of Urological Pathology (ISUP) Consultation Conference on Molecular Pathology of Urogenital Cancers

    Authors: Leendert H. J. Looijenga, Theodorus van der Kwast, David J. Grignon, Lars Egevad, Glen Kristiansen, Chia‐Sui Kao, Muhammad T. Idrees - The American Journal of Surgical Pathology 2020 cited by 59

  24. Androgen suppression adjuvant to definitive radiotherapy in prostate carcinoma—long-term results of phase III RTOG 85–31

    Authors: Miljenko V. Pilepich, Kathryn Winter, C.A. Lawton, Robert E. Krisch, Harvey B. Wolkov, Benjamin Movsas, Eugen B. Hug, Sucha O. Asbell, David J. Grignon - International Journal of Radiation Oncology*Biology*Physics 2005 cited by 920